What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to disclose the entry into material definitive agreements related to executive compensation, specifically the approval of restricted share and non-qualified stock option awards for HCA's executive officers, and the establishment of the 2006 Senior Officer Performance Excellence Program.

How are the restricted shares and stock options structured for executive officers?

Restricted shares will vest over five years, with 20% vesting annually. Stock options will be granted in four installments throughout 2006, with each installment vesting 25% annually over four years. Both types of awards include provisions for accelerated vesting under specific conditions such as change in control, death, or disability.

What are the key performance metrics for the 2006 Senior Officer Performance Excellence Program?

The key performance metrics for the company's five most highly compensated executive officers under the 2006 Senior Officer Performance Excellence Program are Earnings Per Share (EPS) and EBITDA. Other participants' performance is based on company financial results and individual goals.

Are there any conditions that could lead to forfeiture of awards under the Senior Officer PEP?

Yes, awards under the Senior Officer Performance Excellence Program can be forfeited if a participant's conduct is found to be inconsistent with the company's mission, values, Code of Conduct, or Corporate Integrity Agreement. Additionally, termination of employment prior to the end of the year (unless due to death or disability) will generally result in forfeiture.

HCA 8-K: Material Agreements

Summary

This 8-K filing from HCA Healthcare, Inc. (HCA) on February 1, 2006, details the approval of new equity awards and a performance incentive program for its executive officers. The Compensation Committee of the Board of Directors granted restricted shares and non-qualified stock options under the HCA 2005 Equity Incentive Plan. These awards are designed to align executive compensation with company performance and shareholder value over the long term, with vesting schedules and specific conditions, including change-in-control provisions. Additionally, the company established the 2006 Senior Officer Performance Excellence Program, a cash-based incentive program tied to key performance metrics like Earnings Per Share (EPS) and EBITDA for its top executives. This program offers a range of potential payouts based on achieving specified performance targets, with provisions for forfeiture under certain circumstances, reinforcing a performance-driven culture. The filing primarily concerns executive compensation and related governance matters.

Key Highlights

1HCA's Compensation Committee approved restricted share and non-qualified stock option awards for executive officers on January 26, 2006.
2Awards are granted under the HCA 2005 Equity Incentive Plan.
3Restricted shares vest ratably over five years, with accelerated vesting upon change in control, death, or disability.
4Stock options vest in four equal installments throughout 2006, with accelerated vesting upon change in control, disability, or retirement (after 2006), and full vesting upon death.
5The 2006 Senior Officer Performance Excellence Program was established to incentivize senior officers through cash awards based on EPS and EBITDA targets.
6Performance targets for the Senior Officer PEP range from 50% to 120% of base salary for covered officers and 30% to 50% for other senior officers, with potential payouts from 50% to 200% of target.
7Forfeiture clauses exist for the Senior Officer PEP if conduct is inconsistent with company values or if employment terminates (except for death or disability).

HCA Healthcare, Inc. 8-K Report, Material Agreement (Feb 1, 2006)

Summary

Key Highlights

Frequently Asked Questions